At this time, posts about NKMAX are rapidly increasing on portals and securities communities. Today, foreigners have net sold 4,000 shares of NKMAX, and institutions have net sold 220,000 shares, according to provisional data. NKMAX is known as a manufacturer of basic pharmaceutical substances and biological products.
As of 1:30 PM on the 5th, NKMAX's stock price is 22,700 KRW, up 9.13% from the previous day, with a trading volume of 2,365,566 shares, which is 192.16% of the average trading volume on the 5th.
In addition to NKMAX, posts by investors are also surging for Hyundai Rotem (064350), ST Pharm (237690), and Wonik IPS (240810).

※ Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
